The National Academy of Medicine (NAM) announced today that more than 100 organizations across the U.S. — including community organizations, hospital and medical systems, academia, nonprofits, and health professional societies — have joined NAM in declaring their commitment to reversing national trends in opioid misuse and overdose.

The National Academy of Medicine (NAM) today announced the 2019 Emerging Leaders in Health and Medicine Scholars. These individuals are early- to mid-career professionals from a wide range of health-related fields, from microbiology and surgery to sociology and biomedical engineering.

When John L. Anderson, president emeritus and distinguished professor of chemical engineering at the Illinois Institute of Technology, was first elected to the National Academy of Engineering almost 30 years ago, he remembers being deeply honored and excited about how the recognition would help his career.

The National Academy of Medicine (NAM) has selected five outstanding health professionals for the class of 2019 NAM Fellowships. The fellows were chosen based on their professional qualifications, reputations as scholars, professional accomplishments, and relevance of current field expertise to the work of the NAM and the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine (the National Academies).

For her role in transforming a safety net hospital into a national model for high-quality, cost-efficient health care, the National Academy of Medicine today announced Patricia Gabow is the recipient of the 2019 Gustav O. Lienhard Award for Advancement of Health Care.

The National Academy of Medicine today announced Daniel Weinberger is the recipient of the 2019 Rhoda and Bernard Sarnat International Prize in Mental Health, for his fundamental role in elucidating the biological origins and genetic expressions of schizophrenia, and for transforming how clinicians, researchers, and the public understand mental illness.

The U.S. is a clear leader in the global bioeconomy landscape, but faces challenges from decentralized leadership, inadequate talent development, cybersecurity vulnerabilities, stagnant investment in fundamental research, and international competition, according to Safeguarding the Bioeconomy, a new report from the National Academies of Sciences, Engineering, and Medicine.

National Academy of Sciences President Emeritus Frank Press — distinguished geophysicist, science adviser to President Jimmy Carter, and National Medal of Science recipient — died on Wednesday, Jan. 29, at his home in Chapel Hill, North Carolina. He was 95.

; Credit: Kaba/Flickr

Tuesday's drought news makes you question whether waiting so long in the drive-thru line will continue to be worth it.

First, today's dryku:
Burger prices rise
Will we turn to other foods?
Burritos' do too

Food:

• Have you noticed the increased food prices at the grocery store? Well, now you're going to see it at your fast food joints too. In-N-Out and Chipotle are having to raise prices on their food. Starbucks has also.

In-N-Out raised the cost of its hamburgers and cheeseburgers by a dime and their famous Double-Double jumped 15 cents to $3.45. French fries were unchanged but soft drinks went up a nickel. (San Gabriel Valley Tribune)

Oil and Water:

• They don't mix, but they separate pretty well. The New York Times looks at how an oil field in the Central Valley also pumps 760,000 gallons of water each day that it sells to a local water district. Article goes on to look at the fight over water use in fracking. (NY Times)

Looting:

• The lowering water levels at Lake Oroville have revealed more prehistoric artifacts. Volunteers are helping rangers by keeping tabs on looters who are digging up the relics. My favorite factoid is about how meth heads are among the many culprits. Does smoking meth cause an uncontrollable digging impulse?

Though many who disturb artifacts may not know any better, others can be troublesome. Among them are insomniac "tweakers" high on methamphetamine. "They just dig and dig like little squirrels," Dobis said. (LA Times)

Witches:

• Dowsers have been the media darlings of the current drought year. Benjamin Radford pokes at the practice and points out why we should trust our suspicions about the water-finding trick. He also gives a history lesson about all the things dowsing has been used to find: water, oil, jewels, murderers... (Discovery)

Maps and charts:

• Finally, I leave you with Weather Underground's latest roundup of water statistics. This year is dry but not the worst on record. Reservoirs are still holding a decent amount of water, especially Pyramid Lake. What's up with that? I'm going to have to look into that. (Weather Underground)

And how has your community been affected by the drought? Share your story with a photo on Twitter or Instagram. Tag it #mydrought. For more details on our photo project, click here.

This content is from Southern California Public Radio. View the original story at SCPR.org.

Money talks ... in verse.

"Money is a kind of poetry," the poet Wallace Stevens once wrote. That might be so, but poems rarely pay the poet's bills. Still, poetry reading in the U.S. has skyrocketed in recent years, according to the National Endowment for the Arts' Survey of Public Participation in the Arts.

The Academy of American Poets announced Thursday that it has received a $4.5 million grant from The Andrew W. Mellon Foundation for the Poets Laureate Fellowship program — believed to be the largest-ever from a philanthropic institution for poetry. That's enough to fund the program for the next three years.

Poetry is like "the little engine that could ... with its outsized power, with its tremendous potency," Elizabeth Alexander, who is the president of the Mellon Foundation, tells NPR. As a poet, she believes the grant will help that engine "move a little faster."

Through fellowships to individual poets laureate, "we're able to create the conditions and open up the creativity of poets, not only to make their own poems, but also to think 'how can communities use poems? How can we let poetry be a way that we can explore what it means to be American in all these different places in real time?,'" Alexander says. (The Mellon Foundation is among NPR's recent financial supporters.)

"It's a game-changer," says poet and former NEA Chair Dana Gioia. He says that while multimillion-dollar grants to performing arts institutions is commonplace, the poetry world has made do on tiny grants from small funders. "Usually it's $25,000 and you're supposed to be grateful."

The Poets Laureate project began last year and provides grants from $50,000 to $100,000 to 13 poets around the country. Molly Fisk, the poet laureate of California's Nevada County, spearheaded workshops that encouraged more than 800 schoolchildren to write poems responding to devastating wildfires in the state. Ed Madden, poet laureate of Columbia, S.C., tells NPR he believes in "poetry as public art," including poetry readings on city buses. For his fellowship, he launched a youth and community workshop and interactive map called "Telling the Stories of the City."

Claudia Castro Luna, Washington state's poet laureate, held workshops at eight stops along the Columbia River — "places where cultural programming of the kind I am providing is rare," she tells NPR. Luna says the yearlong project One River, Many Voices "brought an injection of joy and beauty, an enthusiasm for words."

Academy of American Poets Chairman Michael Jacobs says in a statement that the organization is "thrilled that this extraordinary grant from the Mellon Foundation will help us continue to fulfill our mission and enable us to meaningfully fund poets who are involved in the civic life of their communities."

The $4.5 million grant is not the largest philanthropic gift to poetry. That distinction goes to Ruth Lilly who pledged an unrestricted $200 million to Chicago's Poetry Foundation in 2002. But it is believed to be the largest grant ever made by a philanthropic institution to support poets.

Gioia says having a large foundation like Mellon put real money toward the art form "is both visionary and practical," and a reflection of poetry's growing popularity among all age levels and backgrounds.

"Thirty years ago, I was seen as an eccentric for loving poetry. Now I'm just stating the obvious," he says. As Gioia's own poem Money puts it:

It greases the palm, feathers a nest, holds heads above water, makes both ends meet.

Guidelines for the 2020 round of fellowships are posted on the Academy of American Poets' website. Poets laureate "of a state, city, county, U.S. territory, or Tribal nation after having been formally appointed" are eligible.

This content is from Southern California Public Radio. View the original story at SCPR.org.

The serious inflammatory syndrome sending some children and teens to the hospital remains extremely uncommon, doctors say. But if your child spikes a high, persistent fever, and has severe abdominal pain and vomiting that doesn't make them feel better, call your doctor as a precaution.; Credit: Sally Anscombe/Getty Images

Sixty-four children and teens in New York State are suspected of having a mysterious inflammatory syndrome that is believed to be linked to COVID-19, the New York Department of Health said in an alert issued Wednesday. A growing number of similar cases — including at least one death — have been reported in other parts of the U.S. and Europe, though the phenomenon is still not well-understood.

Pediatricians say parents should not panic; the condition remains extremely rare. But researchers also are taking a close look at this emerging syndrome, and say parents should be on the lookout for symptoms in their kids that might warrant a quick call to the doctor — a persistent high fever over several days and significant abdominal pains with repeated vomiting, after which the child does not feel better.

"If [the child is] looking particularly ill, you should definitely call the doctor," says Dr. Sean O'Leary, a pediatric infectious disease specialist at Children's Hospital Colorado Anschutz Medical Campus and member of the infectious disease committee for the American Academy of Pediatrics.

The new condition associated with COVID-19 is called Pediatric Multi-System Inflammatory Syndrome. Symptoms include persistent fever, extreme inflammation, and evidence of one or more organs that are not functioning properly, says cardiologist Jane Newburger, a professor of pediatrics at Harvard Medical School and director of the Kawasaki Program at Boston Children's Hospital.

"It's still very rare, but there's been a wave of cases. Physicians and scientists are working hard to understanding the mechanisms at play, and why only some children are so severely affected," Newburger says.

Some symptoms can resemble features of Kawasaki Disease Shock Syndrome. Kawasaki Disease is an acute illness in children involving fever, together with symptoms of rash, conjunctivitis, redness in the lips, tongue and mucous membranes of the mouth and throat, swollen hands and/or feet, and sometimes a large group of lymph nodes on one side of the neck, says Newburger. Some children with the condition develop enlargement of the coronary arteries and aneurysms in those blood vessels.

A small percentage of Kawasaki cases go on to develop symptoms of shock – which can include a steep drop in systolic blood pressure and difficulty with sufficient blood supply to the body's organs. Kawasaki disease and KDSS more often affect young children, although they can sometimes affect teens, Newburger says.

Some cases of the new inflammatory syndrome have features that overlap with KD or with KDSS — including rash, conjunctivitis, and swollen hands or feet. The new inflammatory syndrome can affect not only young children but also older children and teens.

But patients with the new syndrome have lab results that look very different, in particular, "cardiac inflammation to a greater degree than we typically see in Kawasaki shock syndrome," which is usually very rare, O'Leary says. In New York City and London, which have seen large numbers of cases of COVID-19 cases, "those types of patients are being seen with greater frequency."

Some patients "come in very, very sick," with low blood pressure and high fever, O'Leary says. Some children have had coronary artery aneurysms, though most have not, he adds.

Other patients exhibit symptoms more similar to toxic shock syndrome, with abdominal pain, vomiting and diarrhea and high levels of inflammation in the body, as well as the heart, O'Leary says. Most cases are treated in the intensive care unit, he says. Treatment includes intravenous immunoglobulin, which can "calm the immune system," says Newburger, as well as steroids and cytokine blockers.

The evidence so far from Europe, where reports of the syndrome first emerged, suggests most children will recover with proper supportive care, says O'Leary, though one adolescent, a 14-year-old boy in London, has died, according to a report published Wednesday in The Lancet.

Most children with the syndrome, O'Leary and Newburger note, have either tested positive for a current infection with the coronavirus, or for antibodies to the virus, which would suggest they were infected earlier and recovered from it.

And, according to case reports, some of the kids with the inflammatory syndrome who tested negative on coronavirus tests had been exposed at some point to someone known to have COVID-19. The inflammatory syndrome can appear days to weeks after COVID-19 illness, doctors say, suggesting the syndrome arises out of the immune system's response to the virus.

"One theory is that as one begins to make antibodies to SARS-COV-2, the antibody itself may be provoking an immune response," says Newburger. "This is only happening in susceptible individuals whose immune systems are built in a particular way. It doesn't happen in everybody. It's still a really uncommon event in children."

In late April, the U.K.'s National Health Service issued an alert to pediatricians about the syndrome. Reports have also surfaced in France, Spain and Italy, and probably number in the dozens globally, Newburger and O'Leary say, though doctors still don't have hard numbers. Newburger says there needs to be a registry where doctors can report cases "so we can begin to generate some statistics."

"Doctors across countries are talking to each other, but we need for there to be some structure and some science so that everybody can interpret," she says.

Earlier this week, the New York City Health Department issued an alert saying 15 children ranging in age from 2 to 15 had been hospitalized with the syndrome. Newburger says that she's been contacted about cases in New Jersey and Philadelphia, as well.

While the syndrome's precise connection to the coronavirus isn't yet clear, O'Leary says the fact that the children in most of these cases are testing positive for exposure to the virus, one way or another, provides one point of evidence. The sheer number of cases — small in absolute terms, but still "much higher than we would expect normally for things like severe Kawasaki or toxic shock syndrome" — provides another, he says.

And then there's the fact that most reports of the syndrome have come out of the U.K. and New York City, places that have been hit with large numbers of COVID-19 cases.

"It's pure speculation at this point," he says, "but the U.K. cluster kind of went up about a month after their COVID-19 infections went up, which would suggest that it is some kind of an immune phenomenon."

This content is from Southern California Public Radio. View the original story at SCPR.org.

Patt Morrison and Stephen Hawking at Cal-Tech. ; Credit: Dave Coelho/KPCC

The renowned physicist, cosmologist and lover of Indian food is at Caltech for his annual dinner and lecture visit. I broke naan across from him Thursday at dinner, which was cooked by a class of adept Caltech students.

I had a short interview with him, and with the student-chefs, which will be airing on “Off-Ramp” soon. As we took the photograph, I had just made a little joke, which accounts for his smile [producer Dave Coelho didn’t get a smile, but maybe he’s not as funny nor as glamorous as I am].  

This content is from Southern California Public Radio. View the original story at SCPR.org.

…and why are they selling it to other security vendors and product testers?

The post Professional data leakage: How did that security vendor get my personal data? appeared first on WeLiveSecurity

Source: Keith Schaefer for Streetwise Reports   04/28/2020

An entirely new—and highly profitable—industry is being borne out in 2020—TeleHealth.

CloudMD Software & Services Inc. (DOC:CSE; DOCRF:OTCQB; 6PH:FSE) is my favorite way to play teleHealth. It's growing quickly with over 100,000 patients registered on its app and over 3000 doctors in 8 provinces in its Electronic Medical Records—EMR—system. It has MULTIPLE revenue streams and it just moved into Canada's largest market—Ontario—setting up an even faster growth rate.

The recent spread of coronavirus is only accelerating this. COVID-19 has forever changed how we all will think about visiting a hospital or seeing our doctor. We really don't want to do that at all, if possible. It will have a very positive and long lasting impact on teleHealth.

teleHealth companies in Canada are getting paid more money for services than bricks-and-mortar clinics, and have a fraction of the costs. Doctors want more of it, patients want more of it, government wants more of it—and the Market REALLY wants more of it. Everybody wins here; there is no downside.

The rapid scale-up and profitability is key for investors.

The stock market is now recognizing this trend—in spades. You can see it in the stock chart of the U.S. leader in teleHealth, Teladoc Health Inc. (TDOC:NYSE).

While the market plummeted Teladoc's business and share price soared.

Now that a firm trend is in place—and teleHealth is one that makes a lot of sense—I'm looking for the junior with the best leverage to this new long term trade.

CloudMD is established, growing quickly and trading at a fraction of its peers.

The average multiple of competitors in the sector trade at 5-7x revenue, and CloudMD is trading way below that at 2.5x per revenue. I'll have more on those comps in a moment.

But realize that the Canadian use of telemedicine is still just a fraction of where it is in the U.S—so the quick, early upside is even bigger.

Literally the Canadian Version of Teladoc Health

The story with this stock is very simple. CloudMD is literally the Canadian version of Teladoc Health—just at an earlier stage in the growth curve.

The market desperately wants to own teleHealth right now (see also the stock charts of LVGO-NASD and CATS-NASD). I see CloudMD as the best way to do that in the junior sector (where the leverage is!).

For this stock to have a major run all that needs to happen is for institutional investors to wake up to the fact that the company exists. That's happening now with the company entering the province of Ontario—which has 14.5 million people, over one-third of Canada's population.

CloudMD is a fully integrated health care company—kind of like a hospital-in-the-sky. They do have five bricks-and-mortar clinics, but they also own their own EMR—Electronic Medical Records—system that operates in eight provinces and is used by over 3,000 doctors and is supported by an in-house 25 person development team. They have their own CloudMD app—which has over 100,000 registered patients already.

Folks, we really are in front of the institutions on this one. I don't have room in this article to even talk to you about the depth and credibility of CEO Dr. Essam Hamza, but after several conversations with him I can say that shareholders are in very good hands.

The EMR gives CloudMD a recurring monthly revenue stream, which The Street loves. The app gives them high margin fees from doctors, specialists and groups like massage therapists and counselors. These people are revenue, not costs. As I said, full hospital-in-the-sky. Multiple revenue sources with lower costs.

To schedule a virtual doctor's appointment all that a patient has to do is download the free CloudMD app and then arrange an appointment with one of the doctors. There is zero charge for the patient and they can see a doctor very quickly.

CloudMD can scale up the number of patients VERY quickly—and they are.

Every aspect of healthcare that's very fractured and disjointed will now be in the one CloudMD ecosystem.

Everyone wins with this system. Patients, doctors, the medical system, society, even investors. Everyone.

TeleHealth Is MUCH More Profitable Than Clinics

Doctors who have signed up with CloudMD work remotely from home or wherever they are (like their winter home down south). The rapid scale-up potential excites me. CloudMD can add in unlimited number of doctors and patients—so it has a virtually unlimited ability to scale quickly with little incremental cost.

Profit margins are wide and there is no cap on the number of customers that can be handled.

After a patient has an appointment, CloudMD bills the government directly just like every bricks-and-mortar clinic in Canada does. CloudMD records 100% of the revenue and gets to keep 30% of the billing for every patient that is seen through telemedicine, which is actually 10% more than what a bricks-and-mortar clinic receives. That is because the governments are trying to push teleHealth.

The doctor gets the other 70% and doesn't have to deal with any headaches of commuting or running a business.

Without the overhead of a bricks-and-mortar clinic, AND more revenue—CloudMD will be much more profitable than traditional health care stocks.

Faster scale, more cash flow. And they just entered Canada's largest market. This is the right stock in the right market at the right time.

When CloudMD goes from one doctor to 10 doctors to 100 doctors working at the same time, they don't have to build more clinics. They don't have to create more rooms for them or hire more staff. They just sign them on. That's it.

And we are not just talking about family doctors. They are also adding specialists and third party services like counseling and physiotherapists to the platform—and again, all these people are revenue, not costs.

That's the great thing about this business model. It's very scalable, very easy, and it grows very quickly.

CloudMD has been growing its recurring SAAS (Software-as-a-Service) revenue by 30% YoY with its EMR system. But this year the company is expecting that doctor growth to be much much higher—with a new full time sales team and the coronavirus pandemic. SaaS revenue is highly lucrative!

Consumer growth (patients) using the CloudMD app is growing even faster. And the recent COVID-19 situation will only turbocharge that.

Another Revenue Stream, Another Win-Win

There's another angle here—pharmacies. CloudMD says they will partner with more than 150 pharmacies in 2020 alone who are afraid of losing prescription business to Amazon (AMZN-NASD).

Those pharmacies are paying $500 a month for CloudMD kiosks to be in their pharmacies—where customers can get a prescription from a doctor on demand.

This keeps the customer in the pharmacy for their prescription—not out to see a doctor and then off to Costco to get it filled.

Pharmacies that don't see the writing on the wall will become the blockbusters of the industry and get left behind.

With the kiosk in the pharmacy, a person can just see a doctor right away, within 10 minutes, and walk the prescription back to the pharmacist.

Buy-outs Are Happening at High Valuations

We know that these businesses are worth.

Grocery giant Loblaws purchased QHR—another Canadian based EMR company—for $3.10/share or 7.5X revenue. Note that QHR's former Chairman Mark Kohler recently joined CloudMD's Board of Directors.

Teladoc bought a company out of Quebec just two months ago called InTouch for about US$600 million, which again is about 7.5X revenue. Teladoc itself trades at more than 10X revenue.

CloudMD trades at 2.5X revenue, less than a third of recent transactions. Meanwhile the company is poised to grow revenues at a high double digit rate for the foreseeable future.

TeleHealth is the future of how our healthcare is delivered.

Everyone has always expected that the growth would be just like what Netflix experienced with streaming, shaped like a hockey stick. The hockey stick shape is slow at the start as early adopters move and then straight up as the mainstream catches up with plot.

The demand for teleHealth from COVID-19 just took the flat part of that hockey stick out of the equation and instead took the industry directly to the exponential growth curve.

The jumping off point for teleHealth is here and I think CloudMD is the best pure-play teleHealth stock right now.

TeleHealth is to healthcare what streaming was to video rentals, and what Amazon was to retail. IT IS THE FUTURE.

Now is the time for investors to get on board, especially in Canada where virtual healthcare only accounts for 0.15% of the market and the growth curve will be much steeper.

And for me, that's CloudMD. It's the new normal. I'm long.

Keith Schaefer is editor and publisher of the Oil & Gas Investments Bulletin. He has a degree in journalism and has worked for several Canadian dailies but has spent over 15 years assisting public resource companies in raising exploration and expansion capital.

Disclosure:
1) Keith Schaefer: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: CloudMD. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: CloudMD. My company has a financial relationship with the following companies mentioned in this article: None. Additional disclosures are listed below.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with CloudMD. Please click here for more information.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of CloudMD, a company mentioned in this article.

Keith Schaefer Disclosures:

Charts provided by the author.

My new book LOSERTHINK, available now on Amazon https://tinyurl.com/rqmjc2a Content: Making the most of our lockdown opportunities The future of the coronavirus task force Testing our way out, versus reality The economy and recovery If you would like to enjoy this same content plus bonus content from Scott Adams, including micro-lessons on lots of useful […]

The post Episode 959 Scott Adams: Join Me in My Fortress of Garagitude appeared first on Scott Adams' Blog.

My new book LOSERTHINK, available now on Amazon https://tinyurl.com/rqmjc2a Content: The Plague of Corruption video General Flynn San Antonio makes phrase “Chinese virus” hate speech Vitamin D deficiency and coronavirus Testing, flattening the curve, magical thinking If you would like to enjoy this same content plus bonus content from Scott Adams, including micro-lessons on lots […]

The post Episode 962 Scott Adams: No One Knows Anything But We Still Have to Decide How to reopen Economy appeared first on Scott Adams' Blog.

Adopting the Green Economy approach will reap greater environmental, social and economic benefits, compared with a society that focuses on economic growth as the measure for future development, according to a recent UN report. Using two per cent of global GDP to ???green??? key sectors could be enough to trigger the transition towards a green economy.

A recent study has provided support for an alternative means of tackling the unsustainability of resource-intensive economic growth. Using examples of best practice, it upholds a model of moderate growth in GDP combined with a significant increase in the environmental technology market and greater resource-efficiency across all industries.

Although the causes of Alzheimer's disease are still unknown, it is clear that the disease commences with progressive amyloid deposition in the brains of affected persons between ten and fifteen years before the emergence of initial clinical symptoms such as memory loss. Researchers have now been able to show that Aducanumab, a human monoclonal antibody, selectively binds brain amyloid plaques, thus enabling microglial cells to remove the plaques. A one-year treatment with the antibody, as part of a phase Ib study, resulted in almost complete clearance of the brain amyloid plaques in the study group patients. The results, which were realized by researchers at UZH together with the biotech company "Biogen" and the UZH spin-off "Neurimmune," have been published in the renowned science journal "Nature."

read more

The current economic and environmental crisis tells us that the time is ripe for governments around the world to implement a new kind of economy, which is resilient, sustainable, operates within the limits of our planet's resources and creates a fairer society. This thematic issue covers research which can help policy makers develop this Global Green Economy.

A recent study has analysed trade unions’ understanding of the relationship between environmental protection and jobs. It identified four reoccurring themes from interviews with union representatives, which provide insight into how trade union environmental agendas could develop under a greener economy.

Researchers have developed a methodology that allows the analysis of how an existing product design meets design guidelines required for the circular-economy perspective, and which guidelines would need to be incorporated to create a better circular-design product. The results, based on a case study of small electrical equipment in Spain, indicate that the most urgent priority is to incorporate circular-design guidelines related to extending life span and to product/components re-use, while there is a moderate need to include guidelines related to the use of simple removable connections or a modular product structure.

To support the move towards a circular economy, in which resources are kept in use for as long as possible to minimise waste, there is great potential for the bioeconomy — those parts of the economy linked to the use of renewable biological resources — to adopt innovative business models and practices, says a new study. However, the study found that bioeconomy businesses instead perceive the circular economy in terms of well-established practices, such as recycling.

Vehicle fuel economy has markedly improved, but there are other factors that influence fuel consumption and transport emissions, according to new research on the EU, USA and Japan. Changes in vehicle size and power also play a role indicating that, if fuel prices do not keep rising, policy focus may need to shift to managing vehicle use.

Waves hitting Europe’s Atlantic coast during the winter of 2013–2014 were the most powerful in nearly 70 years, reports a new study. They caused significant coastal erosion and the study found examples of beaches which are now several metres lower. The study’s authors say that coastal planners should consider increasingly stormy conditions in the north-east Atlantic, as predicted by some climate change models.

The most effective way to lower the greenhouse gas (GHG) emissions associated with metal production is to pursue a circular economy for the material in the long term, says a recent study. This century will see a high demand for seven major metals; the resultant overall environmental impact is expected to outweigh any environmental savings that may result from greener production processes or an increased use of renewable energy.

Around 50% of gold in used mobile phones is not recovered for future use, a new study finds. The researchers suggest that a global circular economy in mobile phones could be created by improving recycling of precious metals in phones in developing countries, as well as increasing the lifespan of phones and improving collection after use. These changes will reduce pressures on non-renewable resources and close ‘metal flow loops’.

A successful circular economy for valuable metals needs more than just effective recycling technologies, as a new study shows. The research, which explored the governance of recovering vanadium from steel-industry waste, revealed that industry stakeholders feel the prospect of financial gain, or reduced costs, through recovery is too distant at present. This perception could hinder a circular economy for critical materials from industrial residue, the study warns.

The potential of recycling aluminium scrap in Austria has been modelled in a new study. A surplus of mixed aluminium scrap is expected by 2045 if no advanced sorting technologies are applied. Increased demand for wrought aluminium alloys could mean this surplus occurs sooner. New methods to intensively sort aluminium could prevent this excess and contribute towards REACH1 recycling and climate targets.

The EU-27 have committed to a strategic goal of developing an innovative economy based on biotechnology and renewable resources — a so-called ‘bioeconomy’. To achieve this, however, the EU must successfully mobilise resources such as residual biomass — or waste products from organic matter resources. A new study1 has quantified the potential of key residual biomass streams in the EU-27. The results show that residual biomass has a theoretical energy potential equivalent to the annual energy consumption of Italy and Belgium combined, with straw and forestry residues comprising the two most productive potential sources. The findings also reveal specific opportunities for regions including Paris (France) and Jaen (south-central Spain).

Improving the energy efficiency of homes could have positive economy-wide impacts, recent UK research suggests. It would allow householders to spend the money they save on energy on other products and services. Although this additional demand and the associated production in non-energy sectors would partly offset the energy saved in the home, this ‘rebound effect’ does not completely outweigh the household energy savings.

An economic analysis of 14 common categories of waste electric and electronic equipment (WEEE) has highlighted the economic value of bringing e-waste streams into the circular economy. The overall worth is calculated as €2.15 billion to European markets, with a potential rise to €3.67 billion as volumes increase.

A circular economy (CE) is one in which materials retain their value and are reused, minimising waste. Cities and councils could act as CE trailblazers by embedding this approach whenever possible into their public purchase of products, services and works. This study explored different approaches to circular public procurement (CPP), and identified possible opportunities to promote CE via appropriate procurement policy and criteria.

A mobile-centric approach and the emergence of new digital platforms fuelling greater adoption of e-commerce has driven reach and growth of MakeMyTrip, the online travel company said in a presentation to investors.

An executive in a large global enterprise claims to be losing 125 minutes per day due to poor communication, collaboration and information flows!*By unifying your voice, instant messaging, collaboration and mobility together, you can boost efficiency and simplify your operations.

In the real-time economy, the demand for cloud services keeps growing with the hybrid cloud as the optimal architecture for handling the inevitable complexity of the agile company’s IT infrastructure.